EN   EN 
 
 
 EUROPEAN  
COMMISSION   
Brussels, XXX   
[…](2020) XXX  draft  
ANNEX  
 
ANNEX  
to the  
Commission Delegated Regulation (EU) ../..  
of XXX amending for the purposes of its adaptation to technical and scientific progress, 
Part 3 of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of 
the Council on classification, labelling and packaging of substances and mixtures    
EN 2  EN ANNEX  
 
In Annex VI to Regulation (EC) No 1272/2008 , Table 3 of Part 3  is amended as follows:  
 
(1) the following entries are inserted : 
Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘601-093-00-6 1,4-dimethylnaphthalene  209-335-9 571-58-4 Acute Tox. 4  
Asp. Tox. 1  
Eye Irrit. 2  
Aquatic Acute 1  
Aquatic 
Chronic 3  H302  
H304  
H319  
H400  
H412  GHS07  
GHS08  
GHS09  
Dgr H302  
H304  
H319  
H410  oral: ATE = 
1300 mg/kg 
bw  
M=1 ‘  
‘601-094-00-1 1-isopropyl -4-
methylbenzene;  
p-cymene  202-796-7 99-87-6 Flam. Liq. 3  
Acute Tox. 3  
Asp. Tox. 1  
Aquatic 
Chronic 2  H226  
H331  
H304  
H411  GHS02  
GHS06  
GHS08  
GHS09  
Dgr H226  
H331  
H304  
H411   inhalation: 
ATE = 3 
mg/l 
(vapours) ’  
‘601-095-00-7 p-mentha -1,3-diene; 1 -
isopropyl -4-
methylcyclohexa -1,3-
diene;  
alpha -terpinene  202-795-1 99-86-5 Flam. Liq. 3  
Acute Tox. 4  
Skin Sens. 1  
Asp. Tox. 1  
Aquatic 
Chronic 2  H226  
H302  
H317  
H304  
H411  GHS02  
GHS07  
GHS08  
GHS09  
Dgr H226  
H302  
H317  
H304  
H411   oral: ATE = 
1680 mg/kg 
bw’   
EN 3  EN  
Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘602-110-00-X tetrafluoroethylene  204-126-9 116-14-3 Carc. 1B  H350  GHS08  
Dgr H350 ’    
‘604-095-00-5 6,6'-di-tert-butyl -2,2'-
methylenedi -p-cresol;  
[DBMC]  204-327-1 119-47-1 Repr. 1B  H360F  GHS08  
Dgr H360F ’    
‘606-152-00-X (5-chloro -2-methoxy -4-
methyl -3-pyridyl)(4,5,6 -
trimethoxy -o-
tolyl)methanone; 
pyriofenone  - 688046 -61-9 Carc. 2  
Aquatic 
Chronic 1  H351  
H410  GHS08  
GHS09  
Wng  H351  
H410   M=1 ’  
‘607-747-00-7 2,2-dibromo -2-
cyanoacetamide; [DBNPA]  233-539-7 10222 -01-2 Acute Tox. 2  
Acute Tox. 3  
STOT RE 1  
Skin Irrit. 2  
Eye Dam. 1  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H330  
H301  
H372 
(respiratory 
tract) 
(inhalation)   
H315  
H318  
H317  
H400  
H410  GHS06  
GHS08  
GHS05  
GHS09  
Dgr H330  
H301  
H372 
(respiratory 
tract) 
(inhalation)   
H315  
H318  
H317  
H410   inhalation: 
ATE = 0,24 
mg/l (dusts 
or mists)   
oral: ATE = 
118 mg/kg 
bw 
M=1  
M=1 ’  
‘607-748-00-2 [S-(Z,E)]-5-(1-hydroxy -
2,6,6 -trimethyl -4-
oxocyclohex -2-en-1-yl)-3-
methylpenta -2,4-dienoic 
acid ;  
S-abscisic acid  244-319-5 21293 -29-8 Aquatic Acute 1  
Aquatic 
Chronic 1  H400  
H410  GHS09  
Wng  H410   M=1  
M=1 ’   
EN 4  EN Index No  Chemical Name  EC No  CAS  No Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘607-749-00-8 methyl salicylate  204-317-7 119-36-8 Repr. 2  
Acute Tox. 4  
Skin Sens. 1B  
Aquatic 
Chronic 3  H361d  
H302  
H317  
H412  GHS07  
GHS08  
Wng  H361d  
H302  
H317  
H412   oral: ATE = 
890 mg/kg 
bw’  
‘607-750-00-3 citric acid  201-069-1 77-92-9  Eye Irrit. 2  
STOT SE 3  H319  
H335  GHS07  
Wng  H319  
H335 ’    
‘607-751-00-9 ethametsulfuron -methyl 
(ISO);   
methyl 2 -({[4-ethoxy -6-
(methylamino) -1,3,5 -
triazin -2-
yl]carbamoyl}sulfamoyl)b
enzoate  - 97780 -06-8 Eye Irrit. 2  
Aquatic Acute 1  
Aquatic 
Chronic 1  H319  
H400  
H410  GHS07  
GHS09  
Wng  H319  
H410   M=1000  
M=100 ’  
‘607-752-00-4 trinexapac -ethyl (ISO);   
ethyl 4 -
[cyclopropyl(hydroxy)met
hylene] -3,5-
dioxocyclohexanecarboxyl
ate - 95266 -40-3 STOT RE 2  
Skin Sens. 1B  
Aquatic 
Chronic 1  H373 
(gastrointestin
al tractGI )  
H317  
H410  GHS08  
GHS07  
GHS09  
Wng  H373 
(gastrointestinal 
tractGI )  
H317  
H410   M=1 ’  
‘607-753-00-X (3aS,5S,6R,7aR,7bS,9aS,10
R,12aS,12bS)-10-
[(2S,3R,4R,5R)-3,4-
dihydroxy -5,6-
dimethylheptan -2-yl]-5,6-
dihydroxy -7a,9a -
dimethylhexadecahydro -
3H-benzo[ c]indeno[5,4 -
e]oxepin -3-one; 24 -
epibrassinolide  - 78821 -43-9 Aquatic  
Chronic 4  H413   H413 ’    
‘607-754-00-5 benzyl salicylate  204-262-9 118-58-1 Skin Sens. 1B  H317  GHS07  
Wng  H317 ’     
EN 5  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘607-755-00-0 (RS)-1-{1-ethyl -4-[4-
mesyl -3-(2-
methoxyethoxy) -o-
toluoyl]pyrazol -5-
yloxy}ethyl methyl 
carbonate;  
tolpyralate  - 1101132 -67-5 Carc. 2  
Repr. 2  
STOT RE 2  
Aquatic Acute 1  
Aquatic 
Chronic 1  H351  
H361fd  
H373 (eye)   
H400  
H410  GHS08  
GHS09  
Wng  H351  
H361fd  
H373 (eye)   
H410   M=10  
M=100 ’  
‘613-337-00-9 prothioconazole (ISO);  
2-[2-(1-
chlorocyclopropyl) -3-(2-
chlorophenyl) -2-
hydroxypropyl] -2,4-
dihydro -3H-1,2,4 -triazole -
3-thione  - 178928 -70-6 Aquatic Acute 1  
Aquatic 
Chronic 1  H400  
H410  GHS09  
Wng  H410   M=10  
M=1 ’  
‘613-338-00-4 azamethiphos (ISO); S-[(6-
chloro -2-oxooxazolo[4,5 -
b]pyridin -3(2H)-yl)methyl] 
O,O-dimethyl 
thiophosphate  252-626-0 35575 -96-3 Carc. 2  
Acute Tox. 3  
Acute Tox. 4  
STOT SE 1  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H351  
H331  
H302  
H370 
(nervous 
system)   
H317  
H400  
H410  GHS06  
GHS08  
GHS09  
Dgr H351  
H331  
H302  
H370 (nervous 
system)   
H317  
H410   inhalation: 
ATE = 0,5 
mg/l (dusts 
or mists)   
oral: ATE = 
500 mg/kg 
bw  
M=1000  
M=1000 ’  
‘613-339-00-X 3-methylpyrazole  215-925-7 1453 -58-3 Repr. 1B  
Acute Tox. 4  
STOT RE 2  
Skin Corr. 1  
Eye Dam. 1  H360D  
H302  
H373 (lung)   
H314  
H318  GHS08  
GHS07  
GHS05  
Dgr H360D  
H302  
H373 (lung)   
H314   oral: ATE = 
500 mg/kg 
bw’   
EN 6  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘613-340-00-5  clomazone (ISO); 2 -(2-
chlorobenzyl) -4,4-
dimethyl -1,2-oxazolidin -3-
one - 81777 -89-1 Acute Tox. 4  
Acute Tox. 4  
Aquatic Acute 1  
Aquatic 
Chronic 1  H332  
H302  
H400  
H410  GHS07  
GHS09  
Wng  H332  
H302  
H410   inhalation: 
ATE = 4,85 
mg/l (dusts 
or mists)   
oral: ATE = 
768 mg/kg 
bw 
M = 1  
M = 1 ’  
‘614-030-00-2 emamectin benzoate (ISO); 
(4’’R)-4’’-deoxy -4’’-
(methylamino) avermectin 
B1 benzoate  - 155569 -91-8 Acute Tox. 3  
Acute Tox. 3  
Acute Tox. 3  
STOT SE 1  
STOT RE 1  
Eye Dam. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H331  
H311  
H301  
H370 
(nervous 
system)   
H372 
(nervous 
system)   
H318  
H400  
H410  GHS06  
GHS05  
GHS08  
GHS09  
Dgr H331  
H311  
H301  
H370 (nervous 
system)   
H372 (nervous 
system)   
H318  
H410   inhalation:   
ATE = 
0,663  
mg/l (dusts 
or mists)   
dermal:   
ATE = 300  
mg/kg bw  
oral: ATE =  
60 mg/kg 
bw 
STOT RE 
1; H372: C 
≥ 5 %; 
STOT RE 
2; H373: 
0,5 % ≤ C 
< 5 %  
M=10000  
M=10000 ’  
‘616-234-00-7 N-methoxy -N-[1-methyl -2-
(2,4,6 -trichlorophenyl) -
ethyl] -3-(difluoromethyl) -
1-methylpyrazole -4-
carboxamide; 
pydiflumetofen  - 1228284 -64-7 Carc. 2  
Repr. 2  
Aquatic Acute 1  
Aquatic 
Chronic 1  H351  
H361f  
H400  
H410  GHS08  
GHS09  
Wng  H351  
H361f  
H410   M=1  
M=1 ’   
EN 7  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘616-235-00-2 N-{2-[[1,1' -
bi(cyclopropyl)] -2-
yl]phenyl} -3-
(difluoromethyl) -1-methyl -
1H-pyrazole -4-
carboxamide; sedaxane  - 874967 -67-6 Carc. 2  
Aquatic Acute 1  
Aquatic 
Chronic 2  H351  
H400  
H411  GHS08  
GHS09  
Wng  H351  
H410   M=1 ’  
 
(2) the entries corresponding to index numbers  005-007-00-2; 005 -008-00-8; 005 -011-00-4; 005 -011-01-1; 005 -011-02-9; 006 -069-
00-3; 006 -076-00-1; 015 -113-00-0; 028 -007-00-4; 029 -002-00-X; 029 -015-00-0; 029 -016-00-6; 029 -017-00-1; 029 -018-00-7; 
029-019-01-X; 029-020-00-8; 029 -021-00-3; 029 -022-00-9; 029 -023-00-4; 601 -029-00-7; 601 -096-00-2; 603 -024-00-5; 603 -066-
00-4; 603 -098-00-9; 606 -004-00-4; 607 -421-00-4; 607 -424-00-0; 607 -434-00-5; 608 -058-00-4; 612 -067-00-9; 612 -252-00-4; 613 -
048-00-8; 613 -102-00-0; 613 -111-00-X; 613 -166-00-X; 613 -208-00-7; 613 -267-00-9; 613 -282-00-0; 616 -032-00-9; 616 -106-00-0 
and 616-113-00-9  are replaced by the following entries  respectively : 
 
Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘005-007-00-2 boric acid [1]   
boric acid [2]  233-139-2 [1]   
234-343-4 [2]  10043 -35-3 
[1]  
11113 -50-1 
[2] Repr. 1B  H360FD  GHS08  
Dgr H360FD ’     
EN 8  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘005-008-00-8 diboron trioxide  215-125-8 1303 -86-2 Repr. 1B  H360FD  GHS08  
Dgr H360FD ’    
‘005-011-00-4 tetraboron disodium 
heptaoxide, hydrate; [1]   
disodium tetraborate, 
anhydrous; [2]  
orthoboric acid, sodium 
salt [3]  235-541-3 [1]   
215-540-4 [2]   
237-560-2 [3]  12267 -73-1 
[1]  
1330 -43-4 [2]   
13840 -56-7 
[3] Repr. 1B  H360FD  GHS08  
Dgr H360FD ’    
‘005-011-01-1 disodium tetraborate 
decahydrate  215-540-4 1303 -96-4 Repr. 1B  H360FD  GHS08  
Dgr H360FD ’    
‘005-011-02-9 disodium tetraborate 
pentahydrate  215-540-4 12179 -04-3 Repr. 1B  H360FD  GHS08  
Dgr H360FD ’    
‘006-069-00-3 thiophanate -methyl (ISO);  
dimethyl (1,2 -
phenylenedicarbamothioyl)
biscarbamate;   
dimethyl 4,4′ -(o-
phenylene)bis(3 -
thioallophanate)  245-740-7 23564 -05-8 Carc. 2  
Muta. 2  
Acute Tox. 4  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H351  
H341  
H332  
H317  
H400  
H410  GHS08  
GHS07  
GHS09  
Dgr H351  
H341  
H332  
H317  
H410   inhalation: 
ATE = 1,7 
mg/l  
(dusts and 
mists)  
 
M=10  
M=10 ’  
‘006-076-00-1 mancozeb (ISO); 
manganese 
ethylenebis(dithiocarbamat
e) (polymeric ) complex 
with zinc salt  - 8018 -01-7 Carc. 2  
Repr. 1B  
STOT RE 2  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H351  
H360D  
H373 
(thyroid, 
nervous 
system)   
H317  
H400  
H410  GHS08  
GHS07  
GHS09  
Dgr H351  
H360D  
H373 (thyroid, 
nervous system)   
H317  
H410   M=10  
M=10 ’   
EN 9  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class  
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘015-113-00-0  tolclofos -methyl (ISO);  
O-(2,6-dichloro -p-tolyl) 
O,O-dimethyl 
thiophosphate  260-515-3 57018 -04-9 Skin Sens. 1B  
Aquatic Acute 1  
Aquatic 
Chronic 1  H317  
H400  
H410  GHS07  
GHS09  
Wng  H317  
H410   M=1  
M=1 ’  
‘028-007-00-4  trinickel disulfide;   
nickel subsulfide; [1]   
heazlewoodite [2]  234-829-6 [1]   
- [2] 12035 -72-2 
[1]  
12035 -71-1 
[2] Carc. 1A  
Muta. 2  
Acute Tox. 3  
STOT RE 1  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H350i  
H341  
H331  
H372**  
H317  
H400  
H410  GHS08  
GHS06  
GHS09  
Dgr H350i  
H341  
H331  
H372**  
H317  
H410   inhalation:   
ATE = 0,92 
mg/l 
 (dusts or 
mists) ’  
‘029-002-00-X dicopper oxide;  
copper  (I) oxide  215-270-7 1317 -39-1 Acute Tox. 4  
Acute Tox. 4  
Eye Dam. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H332  
H302  
H318  
H400  
H410  GHS07  
GHS05  
GHS09  
Dgr H332  
H302  
H318  
H410   inhalation: 
ATE = 3,34 
mg/l (dusts 
or mists)  
oral: ATE = 
500 mg/kg 
bw 
M=100  
M=10 ’  
‘029-015-00-0 copper thiocyanate  214-183-1   
 1111 -67-7  
 Aquatic Acute 1  
Aquatic 
Chronic 1  H400  
H410  GHS09  
Wng  H410  EUH032  M=10  
M=10 ’  
‘029-016-00-6 copper(II) oxide  215-269-1 1317 -38-0 Aquatic Acute 1  
Aquatic 
Chronic 1  H400  
H410  GHS09  
Wng  H410  
  M=100  
M=10 ’   
EN 10  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘029-017-00-1 dicopper chloride 
trihydroxide  215-572-9 1332 -65-6 Acute Tox. 4  
Acute Tox. 3  
Aquatic Acute 1  
Aquatic 
Chronic 1  H332  
H301  
H400  
H410  GHS06  
GHS09  
Dgr H332  
H301  
H410   inhalation: 
ATE = 2,83 
mg/l (dusts 
or mists)  
oral: ATE = 
299 mg/kg 
bw 
M=10  
M=10 ’  
‘029-018-00-7 tetracopper hexahydroxide 
sulphate; [1]  
tetracopper hexahydroxide 
sulphate hydrate [2]  215-582-3 [1]  
215-582-3 [2]  
 1333 -22-8 [1]  
12527 -76-3 
[2] Acute Tox. 4  
Aquatic Acute 1  
Aquatic 
Chronic 1  H302  
H400  
H410  GHS07  
GHS09  
Wng  H302  
H410   oral: ATE = 
500 mg/kg 
bw 
M=10  
M=10 ’  
‘029-019-01-X copper flakes (coated with 
aliphatic acid)  - - Acute Tox. 3  
Acute Tox. 4  
Eye Irrit. 2  
Aquatic Acute 1  
Aquatic 
Chronic 1  H331  
H302  
H319  
H400  
H410  GHS06  
GHS09  
Dgr H331  
H302  
H319  
H410   inhalation: 
ATE = 
0,733 mg/l 
(dusts or 
mists)  
oral: ATE = 
500 mg/kg 
bw 
M=10  
M=10 ’   
EN 11  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘029-020-00-8 copper(II) carbonate --
copper(II) hydroxide (1:1)  235-113-6 12069 -69-1 Acute Tox. 4  
Acute Tox. 4  
Eye Irrit. 2  
Aquatic Acute 1  
Aquatic 
Chronic 1  H332  
H302  
H319  
H400  
H410  GHS07  
GHS09  
Wng  H332  
H302  
H319  
H410   inhalation: 
ATE = 1 ,2 
mg/l (dusts 
or mists)  
oral: ATE = 
500 mg/kg 
bw 
M=10  
M=10 ’  
‘029-021-00-3 copper dihydroxide;  
copper(II) hydroxide  243-815-9 20427 -59-2 Acute  Tox. 2  
Acute Tox. 4  
Eye Dam. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H330  
H302  
H318  
H400  
H410  GHS06  
GHS05  
GHS09  
Dgr  H330  
H302  
H318  
H410   inhalation: 
ATE = 0, 47 
mg/l (dusts 
or mists)  
oral: ATE = 
500 mg/kg 
bw 
M=10  
M=10 ’  
‘029-022-00-9 bordeaux mixture;  
reaction products of copper 
sulphate with calcium 
dihydroxide  - 8011 -63-0 Acute Tox. 4  
Eye Dam. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H332  
H318  
H400  
H410  GHS07  
GHS05  
GHS09  
Dgr H332  
H318  
H410   inhalation: 
ATE = 1,97 
mg/l (dusts 
or mists)  
 
M=10  
M=1 ’ 
   
‘029-023-00-4 copper sulphate 
pentahydrate  231-847-6 7758 -99-8 Acute Tox. 4  
Eye Dam. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H302  
H318  
H400  
H410  GHS07  
GHS05  
GHS09  
Dgr H302  
H318  
H410   oral: ATE = 
481 mg/kg 
bw 
M=10  
M=1 ’   
EN 12  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘601-029-00-7 dipentene;  
limonene [1]   
 (S)-p-mentha -1,8-diene; l -
limonene [2]   
trans -1-methyl -4-(1-
methylvinyl)cyclohexene; 
[3]  
 (±)-1-methyl -4-(1-
methylvinyl)cyclohexene  
[4] 205-341-0 [1]   
227-815-6 [2]   
229-977-3 [3]   
231-732-0 [4]  138-86-3 [1]   
5989 -54-8 [2]   
6876 -12-6 [3]   
7705 -14-8 [4]  Flam. Liq. 3  
Skin Irrit. 2  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H226  
H315  
H317  
H400  
H410  GHS02  
GHS07  
GHS09  
Wng  H226  
H315  
H317  
H410    C’ 
‘601-096-00-2 (R)-p-mentha -1,8-diene;  
d-limonene  227-813-5 5989 -27-5 Flam. Liq.  3 
Skin Irrit. 2  
Skin Sens. 1B  
Asp. Tox. 1  
Aquatic Acute 1  
Aquatic 
Chronic 3  H226  
H315  
H317  
H304  
H400  
H412  GHS02  
GHS07  
GHS08  
GHS09  
Dgr H226  
H315  
H317  
H304  
H410   M=1 ’  
‘603-024-00-5 1,4-dioxane  204-661-8 123-91-1 Flam. Liq. 2  
Carc. 1B  
STOT SE 3  
Eye Irrit. 2 H225  
H350  
H335  
H319  GHS02  
GHS08  
GHS07  
Dgr H225  
H350  
H335  
H319  EUH019  
EUH066   D’ 
‘603-066-00-4 7-oxa-3-
oxiranylbicyclo[4.1.0]hept
ane; 1,2 -epoxy -4-
epoxyethylcyclohexane; 4 -
vinylcyclohexene 
diepoxide  203-437-7 106-87-6 Carc. 1B  
Muta. 2  
Repr. 1B  
Acute Tox. 3  
Acute Tox. 4  H350  
H341  
H360F  
H331  
H302  GHS08  
GHS06  
Dgr H350  
H341  
H360F  
H331  
H302   inhalation: 
ATE = 0,5 
mg/l (dusts 
or mists)  
oral: ATE = 
1847 mg/kg 
bw’   
EN 13  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)    
‘603-098-00-9 2-phenoxyethanol  204-589-7 122-99-6 Acute Tox. 4  
STOT SE 3  
Eye Dam. 1  H302  
H335  
H318  GHS05  
GHS07  
Dgr H302  
H335  
H318   oral:  
ATE  = 
1394 mg/kg 
bw’  
‘606-004-00-4 4-methylpentan -2-one; 
isobutyl methyl ketone  203-550-1 108-10-1 Flam. Liq. 2  
Carc. 2  
Acute Tox. 4  
STOT SE 3  
Eye Irrit. 2  
 H225  
H351  
H332  
H336  
H319  
 GHS02  
GHS07  
GHS08  
Dgr H225  
H351  
H332  
H336  
H319  EUH066  inhalation: 
ATE =  11 
mg/l 
(vapours) ’  
‘607-421-00-4 cypermethrin (ISO);  
α-cyano -3-phenoxybenzyl 
3-(2,2-dichlorovinyl) -2,2-
dimethylcyclopropanecarb
oxylate; cypermethrin 
cis/trans +/ - 40/60  257-842-9 52315 -07-8 Acute Tox. 4  
Acute Tox. 4  
STOT SE 3  
STOT RE 2  
Aquatic Acute 1  
Aquatic 
Chronic 1  H332  
H302  
H335  
H373 
(nervous 
system)   
H400  
H410  GHS07  
GHS08  
GHS09  
Wng  H332  
H302  
H335  
H373 (nervous 
system)   
H410   oral; ATE = 
500 mg/kg 
bw 
inhalation; 
ATE = 3,3 
mg/l (dusts 
or mists)   
M=100000  
M=100 000’  
‘607-424-00-0 trifloxystrobin (ISO); 
methyl ( E)-methoxyimino -
{(E)-α-[1-(α,α,α -trifluoro -
m-
tolyl)ethylideneaminooxy] -
o-tolyl}acetate  - 141517 -21-7 Lact.   
Skin Sens. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H362  
H317  
H400  
H410  GHS07  
GHS09  
Wng  H362  
H317  
H410   M=100  
M=10 ’   
EN 14  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘607-434-00-5 mecoprop -P (ISO) [1] and 
its salts;  
(R)-2-(4-chloro -2-
methylphenoxy)propionic 
acid [1] and its salts  240-539-0 [1]  16484 -77-8 
[1] Acute Tox. 4  
Eye Dam. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H302  
H318  
H400  
H410  GHS07  
GHS05  
GHS09  
Dgr H302  
H318  
H410   oral: ATE = 
431 mg/kg 
bw 
M=10  
M=10 ’  
‘608-058-00-4 esfenvalerate (ISO);  
(S)-α-cyano -3-
phenoxybenzyl -(S)-2-(4-
chlorophenyl) -3-
methylbutyrate  - 66230 -04-4 Acute Tox. 3  
Acute Tox. 3  
STOT SE 1  
STOT RE 2  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H331  
H301  
H370 
(nervous 
system)   
H373  
H317  
H400  
H410  GHS06  
GHS08  
GHS09  
Dgr H331  
H301  
H370 (nervous 
system)   
H373  
H317  
H410   oral; ATE = 
88,5 mg/kg 
bw 
inhalation; 
ATE = 0,53 
mg/l (dusts 
or mists)   
M=10000  
M=10000 ’  
‘612-067-00-9 3-aminomethyl -3,5,5 -
trimethylcyclohexylamine  220-666-8 2855 -13-2 Acute Tox. 4  
Skin Corr. 1B  
Eye Dam. 1  
Skin Sens. 1 A H302  
H314  
H318  
H317  GHS05  
GHS07  
Dgr H302  
H314  
H317   oral: ATE = 
1030 mg/kg 
bw 
Skin Sens. 
1A; H317: 
C ≥ 
0,001% ’  
‘612-252-00-4 imidacloprid (ISO);  
(E)-1-(6-chloro -3-
pyridylmethyl) -N-
nitroimidazolidin -2-
ylideneamine;  
(2E)-1-[(6-chloropyridin -
3-yl) methyl] -N-
nitroimidazolidin -2-imine  428-040-8 138261 -41-3 Acute Tox. 3  
Aquatic Acute 1  
Aquatic 
Chronic 1  H301  
H400  
H410  GHS06  
GHS09  
Dgr H301  
H410   oral: ATE = 
131 mg/kg 
bw 
M=100  
M=1000 ’   
EN 15  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s ) Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘613-048-00-8 carbendazim (ISO); methyl 
benzimidazol -2-
ylcarbamate  234-232-0 10605 -21-7 Muta. 1B  
Repr. 1B  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic 
Chronic 1  H340  
H360FD  
H317  
H400  
H410  GHS07  
GHS08  
GHS09  
Dgr H340  
H360FD  
H317  
H410   M=10  
M=10 ’  
‘613-102-00-0 dimethomorph (ISO); 
(E,Z)-4-(3-(4-
chlorophenyl) -3-(3,4-
dimethoxyphenyl)acryloyl)
morpholine  404-200-2 110488 -70-5 Repr. 1B  
Aquatic 
Chronic 2  H360F  
H411  GHS08  
GHS09  
Dgr H360F  
H411 ’    
‘613-111-00-X  1,2,4 -triazole  206-022-9 288-88-0 Repr. 1B  
Acute Tox. 4  
Eye Irrit. 2  H360FD  
H302  
H319  GHS08  
GHS07  
Dgr H360FD  
H302  
H319   oral: ATE = 
1320 mg/kg 
bw’  
‘613-166-00-X flumioxazin (ISO);  
N-(7-fluoro -3,4-dihydro -3-
oxo-4-prop-2-ynyl-2H-1,4-
benzoxazin -6-yl)cyclohex -
1-ene-1,2-dicarboximide  - 103361 -09-7 Repr. 2  
Aquatic Acute 1  
Aquatic 
Chronic 1  H361d  
H400  
H410  GHS08  
GHS09  
Wng  H361d  
H410   M=1000  
M=1000 ’  
‘613-208-00-7 imazamox (ISO);  
(RS)-2-(4-isopropyl -4-
methyl -5-oxo-2-
imidazolin -2-yl)-5-
methoxymethylnicotinic 
acid - 114311 -32-9 Repr. 2  
Aquatic Acute 1  
Aquatic 
Chronic 1  H361d  
H400  
H410  GHS08  
GHS09  
Wng  H361d  
H410   M=10  
M=10 ’   
EN 16  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s ) Pictogram, 
Signal 
Word   Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement Code(s)  
‘613-267-00-9 thiamethoxam (ISO);  
3-(2-chloro -thiazol -5-
ylmethyl) -5-
methyl[1,3,5]oxadiazinan -
4-ylidene -N-nitroamine  428-650-4 153719 -23-4 Repr. 2  
Acute Tox. 4  
Aquatic Acute 1  
Aquatic 
Chronic 1  H361fd  
H302  
H400  
H410  GHS07  
GHS08  
GHS09  
Wng  H361fd  
H302  
H410   oral: ATE = 
780 mg/kg 
bw 
M=10  
M=10 ’  
‘613-282-00-0 triticonazole (ISO);  
(RS)-(E)-5-(4-
chlorobenzylidene) -2,2-
dimethyl -1-(1H-1,2,4 -
triazol -1-
methyl)cyclopentanol  - 138182 -18-0 Repr. 2  
STOT RE 2  
Aquatic Acute 1  
Aquatic 
Chronic 1  H361f  
H373  
H400  
H410  GHS08  
GHS09  
Wng  H361f  
H373  
H410   M=1  
M=1 ’  
‘616-032-00-9 diflufenican (ISO);  
N-(2,4-difluorophenyl) -2-
[3-
(trifluoromethyl)phenoxy] -
3-pyridinecarboxamide; 
2′,4′-difluoro -2-(α,α,α -
trifluoro -m-tolyloxy) 
nicotinanilide  - 83164 -33-4 Aquatic Acute 1  
Aquatic 
Chronic 1  H400  
H410  GHS09  
Wng  H410   M=10000  
M=1000 ’  
‘616-106-00-0 phenmedipham (ISO); 
methyl 3 -(3-
methylcarbaniloyloxy)carb
anilate  237-199-0 13684 -63-4 Aquatic Acute 1  
Aquatic 
Chronic 1  H400  
H410  GHS09  
Wng  H410   M=10  
M=10 ’  
‘616-113-00-9 desmedipham (ISO);  
ethyl 3-
phenylcarbamoyloxypheny
lcarbamate  237-198-5 13684 -56-5 Repr. 2  
Aquatic Acute 1  
Aquatic 
Chronic 1  H361d  
H400  
H410  GHS08  
GHS09  
Wng  H361d  
H410   M=10  
M=10 ’   
EN 17  EN  
(3) the entr y corresponding to index number 015-192-00-1 is deleted.   